LEE'S PHARM News

LEE'S PHARM: Voluntary Announcement - The First Patient in Hong Kong Receives AU409, a Novel Drug Product Manufactured by Zhaoke Guangzhou, in a Phase I Liver Cancer Clinical Trial

Aug 1 09:35 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 1 09:28 ET

LEE'S PHARM: List of Directors and their Roles and Functions

Jul 2 07:28 ET

LEE'S PHARM: Appointment of Non-Executive Director

Jul 2 07:19 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 2 07:04 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 3 06:35 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 2 04:03 ET

LEE'S PHARM: Notification Letter to Non-registered Shareholders and Reply Form

Apr 19 06:33 ET

LEE'S PHARM: Notification Letter to Registered Shareholders and Reply Form

Apr 19 06:28 ET

LEE'S PHARM: Proxy Form

Apr 19 06:18 ET

LEE'S PHARM: Environmental, Social and Governance Report 2023

Apr 19 06:01 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 2 03:19 ET

LEE'S PHARM: Final Dividend for the Year Ended 31 December 2023

Mar 26 04:58 ET

LEE'S PHARM: Letter to Non-registered Shareholders - Arrangement for Electronic Dissemination of Corporate Communications and Reply Form

Mar 13 05:13 ET

LEE'S PHARM: Letter to Registered Shareholders - Arrangement for Electronic Dissemination of Corporate Communications and Reply Form

Mar 13 05:10 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 1 04:52 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 1 04:51 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 3 05:06 ET

LEE'S PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 1, 2023 00:21 ET

LEE'S PHARM: Voluntary Announcement - Adasuve Obtains Drug Registration Certificate

Nov 28, 2023 09:23 ET